© 2019 AbbVie Inc.
QUESTIONS ABOUT COVID-19?
We understand your need to know more about COVID-19. If you are on RINVOQ (upadacitinib), please speak with your doctor regarding any questions you may have.
Has COVID-19 made paying for your medicine a challenge? AbbVie may be able to help. 1.800.2RINVOQ
Here for you now.
- Resources and personalized support
- Answers to insurance and pharmacy questions
- Information about the RINVOQ Complete Savings Card
- Further assistance — call 1.800.2RINVOQ

Savings on RINVOQ are available
If you are a commercially insured patient, you may pay as little as $5 a month* with the RINVOQ Complete Savings Card. No matter your financial or job status, there may be ways to lower the amount you pay for RINVOQ.

Resources designed around you
RINVOQ Complete provides a 1:1 personalized experience based on what you need, when you need it – from helping make sense of your insurance coverage to finding ways to help you save. To learn more, call 1.800.2RINVOQ
For more information about what AbbVie is doing to address the global COVID-19 crisis, please visit
https://www.abbvie.com/coronavirus.html.
*Terms and Conditions apply. This benefit covers RINVOQ™ (upadacitinib) alone or for RINVOQ plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eligibility: Available to patients with commercial prescription insurance coverage for RINVOQ who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the RINVOQ Complete Savings Card and patient must call RINVOQ Complete at 1.800.2RINVOQ to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the RINVOQ Complete program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. Patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, co-insurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored co-pay assistance for such drugs (often termed "maximizer" programs) will have an annual maximum program benefit of $6,000.00 per calendar year. This assistance offer is not health insurance. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html
Arava and Plaquenil are registered trademarks of their respective owners.